
Join to view full profile
4400 S 700 ESte 200Salt Lake City, UT 84107
Phone+1 801-264-4444
Fax+1 801-281-2383
Dr. Faber is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- David Faber, MD, is an ophthalmologist based in Salt Lake City, UT, with a subspecialty in retinal disease. He completed his medical education at the University of California San Diego School of Medicine, followed by an internal medicine internship at St. Joseph's Hospital and Medical Center in Phoenix, AZ, and an ophthalmology residency at the University of California (San Diego) Medical Center, with subsequent fellowships in vitreoretinal surgery and ocular oncology in Memphis, TN. Dr. Faber is experienced in vitreoretinal diseases and ocular oncology. He has published research on macular degeneration and diabetic retinopathy treatments and has received the Top MD award from Consumers Checkbook and is a Fellow of the American Academy of Ophthalmology.
Education & Training
University of California (San Diego) Medical CenterResidency, Ophthalmology, 1992 - 1995
Creighton University School of Medicine-PhoenixInternship, Internal Medicine, 1991 - 1992
University of California San Diego School of MedicineClass of 1991
Certifications & Licensure
MT State Medical License 1998 - 2028
UT State Medical License 1997 - 2028
NV State Medical License 2000 - 2027
WY State Medical License 1998 - 2027
ID State Medical License 1998 - 2020
AR State Medical License 1995 - 2010
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification IntelleChart, MDIntelleSys, A Nextech Company, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification IntelleChart, MDIntelleSys, A Nextech Company, 2013-2014, 2016-2017
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 23 citationsOutcomes and Control Rates for I-125 Plaque Brachytherapy for Uveal Melanoma: A Community-Based Institutional ExperienceAaron E. Wagner, Andy Chen, Taylor Cook, David Faber, Kirk Winward
ISRN Ophthalmology. 2014-03-09
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









